Amylyx 制药 AMLX
$29.50 +$1.88 (+6.81%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $30.16 +2.24%
开盘$27.73
昨收$27.62
当日区间$27.50 – $29.58
成交量1.86M
市值$3.79B
市盈率（TTM）–
股息率–
AMLX 相关新闻
匹配 Amylyx Pharmaceuticals 或代码 AMLX 的头条新闻，按最新排序。
- Baird Initiates Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Announces Target Price $28
- A Quick Look at Today's Ratings for Amylyx Pharmaceuticals(AMLX.US), With a Forecast Between $24 to $34
- Citi Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $26
- Citi Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $26 正面
- Guggenheim Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $57 正面
- LifeSci Capital Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $44
- H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $55
- Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $42
- TD Cowen Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating
- Guggenheim Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $55 正面
- A Quick Look at Today's Ratings for Amylyx Pharmaceuticals(AMLX.US), With a Forecast Between $32 to $55
- Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $30 正面
- LifeSci Capital Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $24
- Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Heart Test Laboratories, Inc. (HSCS) and Align Tech (ALGN)
- Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $24 正面
暂无评论——快来第一个聊聊 AMLX。
登录后参与讨论。